Written by internationally renowned experts, the 4rd edition of this book provides detailed practical guidance and advice on the diagnosis and management of the complete range of ocular cancers.
Pioneering work on hepatitis B virus and hepatitis delta virus, and the discovery of hepatitis B-like virus in animals during the 1970's has been followed, over the past ten years, by an explosion of interest in how these viruses replicate, maintain chronic infections, and cause liver disease and hepatocellular carcinoma.
Over the past decade interventional radiology techniques have replaced surgical and clinically guided diagnostic procedures such that the vast majority of patients have a non surgical diagnosis of a breast problem.
Molecular Approach to Cancer Management discusses molecular mechanisms of cancer initiation, growth and secondary spread, emphasizing how this information can be used to devise new modes of treatment of cancer, especially in combatting secondary spread.
Surgical Oncology: An Algorithmic Approach presents the full spectrum of current cancer treatment options available to the practicing general surgeon or trainee.
Biochemical Modulation at the present time defines an area of study in which the intracellular metabolism of a given anti- cancer agent is modulated (usually by a noncytotoxic agent or a cytotoxic agent at sufficiently low dosage to make it non- cytotoxic) in order to either increase the effectiveness of the particular agent against tumor cells or decrease its cytotox- icity against normal cells.
Oncoplastic and Reconstructive Management of the Breast, Third Edition provides a comprehensive and contemporary account of techniques in oncoplastic and reconstructive breast surgery.
Drug Resistance as a Biochemical Target in Cancer Chemotherapy covers the proceedings of the 13th Bristol-Myers Squibb Symposium on Cancer Research, entitled "e;"e;Drug Resistance as a Biochemical Target in Cancer Chemotherapy"e;"e;, hosted by the Japanese Foundation for Cancer Research in Tokyo.
The "e;Europe against Cancer"e; programme has, from its inception, emphasised the key role which general practitioners must play in the actions necessary to achieve its aim of reduc- ing the incidence and the mortality from cancer in the European Community.
In Heterogeneous Nanocomposite-Photocatalysis for Water Purification, the authors introduce various heterogeneous photocatalysts based on novel nanostructures of metal oxide semiconductors and graphene used for water purification, including TiO2, Fe2O3, SnO2, WO3 and g-C3N4, and outlines their advantages and drawbacks.
This visual manual is an accessible guide to musculoskeletal image interpretation and reporting, including common trauma pathologies, arthropathies, mechanisms of injury and classification systems.
This book provides a comprehensive overview of the multidisciplinary management of meningiomas, followed by evaluation and management considerations along a spectrum of benign to more malignant behavior.
This book comprises protocols describing systems biology methodologies and computational tools, offering a variety of ways to analyze different types of high-throughput cancer data.
Cancer is extremely common and in many situations a truly frightening disease, but for too long the psychological aspects and effects have been ignored.
This text presents serious challenges for trainees, clinicians, and practicing pathologists and cytopathologists due to the wide spectrum of diagnoses that may be seen in children and the lack of familiarity with these entities.
Dieses Werk legt eine solide und fundierte onkologische Wissensbasis; es zeigt auf, warum Menschen an Krebs erkranken, wie der Körper auf Krebs reagiert und welche Präventions- und Behandlungsmöglichkeiten es für verschiedene Krebserkrankungen gibt.
Highly Commended in the category of Oncology at the British Medical Association Awards 2019 The accessible guide to the principles behind new, more targeted drug treatments for cancer Written for anyone who encounters cancer patients, cancer data or cancer terminology, but have no more than a passing knowledge of cell biology.
This text is constructed to educate clinicians on the general classification and diagnostic approach to soft tissue tumors, such that they feel more empowered to discuss the relevant features of particular cases with their pathology colleagues.
While drug therapies developed in the last 80 years have markedly improved treatment outcomes and the management of some types of cancers, the lack of effectiveness and side effects associated with the most common treatment types remain unacceptable.
Apoptosis is currently one of the fastest moving fields in biology with spectacular progress made over the past few years in delineating the molecular It is now indisputable that apoptosis mechanisms which underlie this process.
In addition to surgery and radiotherapy, local treatment modalities for the management of brain tumours are increasingly being developed and clinically tested.
This detailed volume gathers a comprehensive collection of methods, protocols, and procedures used for the identification, characterization, and selection of cancer stem cells.
This volume provides an integrated account of our current understanding of the functions of D-type cyclins during development and tumorigenesis, with special emphasis on the kinase-independent functions of these proteins.
This volume presents the most current reviews on how cancer stem cells (CSCs) hypothesis dictates that the continued proliferation of a tumor is dependent on a sub-population of self-renewing and asymmetrically dividing neoplastic stem cells that supply a largely differentiated tumor.
This book presents experimental investigations and digital image processing, highlighting the interaction of polarized radiation with phase-inhomogeneous and optically anisotropic biological layers.
This volume explores the latest collection of cell models that are used in preclinical cancer research, and covers both two-dimensional and three-dimensional culturing techniques.
Effective care of the cancer patient increasingly involves systemic treatment, and as the range of available therapeutic agents continues to expand, the medical oncologist must be fully aware of the rationale for choosing specific drugs and combinations.